Impact of COVID-19 Outbreak on Lung Surfactants, Global Market Research Report 2020

June 2020 | 92 pages | ID: I494734B217FEN
QYResearch

Abstracts

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lung Surfactants market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Lung Surfactants industry.
Segment by Route of Administration, the Lung Surfactants market is segmented into

• Intratracheal
• Injectable

Segment by Application

• Hospital
• Special Clinic
• Recovery Center

Global Lung Surfactants Market: Regional Analysis
The Lung Surfactants market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Route of Administration and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Lung Surfactants market report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE

Global Lung Surfactants Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Lung Surfactants market include:

• Chiesi Farmaceutici
• AbbVie
• ONY Biotech
• Lyomark Pharma
• Windtree Therapeutics
• Aviva Systems Biology Corporation

Contents

1 LUNG SURFACTANTS MARKET OVERVIEW

1.1 Product Overview and Scope of Lung Surfactants
1.2 Covid-19 Impact on Lung Surfactants Segment by Route of Administration
  1.2.1 Global Lung Surfactants Sales Growth Rate Comparison by Route of Administration (2021-2026)
  1.2.2 Intratracheal
  1.2.3 Injectable
1.3 Covid-19 Impact on Lung Surfactants Segment by Application
  1.3.1 Lung Surfactants Sales Comparison by Application: 2020 VS 2026
  1.3.2 Hospital
  1.3.3 Special Clinic
  1.3.4 Recovery Center
1.4 Covid-19 Impact on Global Lung Surfactants Market Size Estimates and Forecasts
  1.4.1 Global Lung Surfactants Revenue 2015-2026
  1.4.2 Global Lung Surfactants Sales 2015-2026
  1.4.3 Lung Surfactants Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Lung Surfactants Industry
1.7 COVID-19 Impact: Lung Surfactants Market Trends

2 COVID-19 IMPACT ON GLOBAL LUNG SURFACTANTS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Lung Surfactants Sales Market Share by Manufacturers (2015-2020)
2.2 Global Lung Surfactants Revenue Share by Manufacturers (2015-2020)
2.3 Global Lung Surfactants Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Lung Surfactants Manufacturing Sites, Area Served, Product Type
2.5 Lung Surfactants Market Competitive Situation and Trends
  2.5.1 Lung Surfactants Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Lung Surfactants Players (Opinion Leaders)

3 COVID-19 IMPACT ON LUNG SURFACTANTS RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Lung Surfactants Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Lung Surfactants Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Lung Surfactants Market Facts & Figures by Country
  3.3.1 North America Lung Surfactants Sales by Country
  3.3.2 North America Lung Surfactants Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Lung Surfactants Market Facts & Figures by Country
  3.4.1 Europe Lung Surfactants Sales by Country
  3.4.2 Europe Lung Surfactants Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Lung Surfactants Market Facts & Figures by Region
  3.5.1 Asia Pacific Lung Surfactants Sales by Region
  3.5.2 Asia Pacific Lung Surfactants Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Lung Surfactants Market Facts & Figures by Country
  3.6.1 Latin America Lung Surfactants Sales by Country
  3.6.2 Latin America Lung Surfactants Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Lung Surfactants Market Facts & Figures by Country
  3.7.1 Middle East and Africa Lung Surfactants Sales by Country
  3.7.2 Middle East and Africa Lung Surfactants Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 UAE

4 COVID-19 IMPACT ON GLOBAL LUNG SURFACTANTS HISTORIC MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

4.1 Global Lung Surfactants Sales Market Share by Route of Administration (2015-2020)
4.2 Global Lung Surfactants Revenue Market Share by Route of Administration (2015-2020)
4.3 Global Lung Surfactants Price Market Share by Route of Administration (2015-2020)
4.4 Global Lung Surfactants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 COVID-19 IMPACT ON GLOBAL LUNG SURFACTANTS HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Lung Surfactants Sales Market Share by Application (2015-2020)
5.2 Global Lung Surfactants Revenue Market Share by Application (2015-2020)
5.3 Global Lung Surfactants Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN LUNG SURFACTANTS BUSINESS

6.1 Chiesi Farmaceutici
  6.1.1 Corporation Information
  6.1.2 Chiesi Farmaceutici Description, Business Overview and Total Revenue
  6.1.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Chiesi Farmaceutici Products Offered
  6.1.5 Chiesi Farmaceutici Recent Development and Response to COVID-19
6.2 AbbVie
  6.2.1 AbbVie Corporation Information
  6.2.2 AbbVie Description, Business Overview and Total Revenue
  6.2.3 AbbVie Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 AbbVie Products Offered
  6.2.5 AbbVie Recent Development and Response to COVID-19
6.3 ONY Biotech
  6.3.1 ONY Biotech Corporation Information
  6.3.2 ONY Biotech Description, Business Overview and Total Revenue
  6.3.3 ONY Biotech Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 ONY Biotech Products Offered
  6.3.5 ONY Biotech Recent Development and Response to COVID-19
6.4 Lyomark Pharma
  6.4.1 Lyomark Pharma Corporation Information
  6.4.2 Lyomark Pharma Description, Business Overview and Total Revenue
  6.4.3 Lyomark Pharma Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Lyomark Pharma Products Offered
  6.4.5 Lyomark Pharma Recent Development and Response to COVID-19
6.5 Windtree Therapeutics
  6.5.1 Windtree Therapeutics Corporation Information
  6.5.2 Windtree Therapeutics Description, Business Overview and Total Revenue
  6.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Windtree Therapeutics Products Offered
  6.5.5 Windtree Therapeutics Recent Development and Response to COVID-19
6.6 Aviva Systems Biology Corporation
  6.6.1 Aviva Systems Biology Corporation Corporation Information
  6.6.2 Aviva Systems Biology Corporation Description, Business Overview and Total Revenue
  6.6.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Aviva Systems Biology Corporation Products Offered
  6.6.5 Aviva Systems Biology Corporation Recent Development and Response to COVID-19

7 LUNG SURFACTANTS MANUFACTURING COST ANALYSIS

7.1 Lung Surfactants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lung Surfactants
7.4 Lung Surfactants Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Lung Surfactants Distributors List
8.3 Lung Surfactants Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Lung Surfactants Market Estimates and Projections by Route of Administration
  10.1.1 Global Forecasted Sales of Lung Surfactants by Route of Administration (2021-2026)
  10.1.2 Global Forecasted Revenue of Lung Surfactants by Route of Administration (2021-2026)
10.2 Lung Surfactants Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Lung Surfactants by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Lung Surfactants by Application (2021-2026)
10.3 Lung Surfactants Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Lung Surfactants by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Lung Surfactants by Region (2021-2026)
10.4 North America Lung Surfactants Estimates and Projections (2021-2026)
10.5 Europe Lung Surfactants Estimates and Projections (2021-2026)
10.6 Asia Pacific Lung Surfactants Estimates and Projections (2021-2026)
10.7 Latin America Lung Surfactants Estimates and Projections (2021-2026)
10.8 Middle East and Africa Lung Surfactants Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Lung Surfactants Sales (K Units) Growth Rate Comparison by Route of Administration (2015-2026)
Table 2. Global Lung Surfactants Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Lung Surfactants Market Size by Route of Administration (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Lung Surfactants Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Lung Surfactants Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Lung Surfactants Players to Combat Covid-19 Impact
Table 9. Global Key Lung Surfactants Manufacturers Covered in This Study
Table 10. Global Lung Surfactants Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Lung Surfactants Sales Share by Manufacturers (2015-2020)
Table 12. Global Lung Surfactants Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Lung Surfactants Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Lung Surfactants Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Lung Surfactants Sales Sites and Area Served
Table 16. Manufacturers Lung Surfactants Product Types
Table 17. Global Lung Surfactants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Lung Surfactants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Surfactants as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Lung Surfactants Players
Table 21. Global Lung Surfactants Sales (K Units) by Region (2015-2020)
Table 22. Global Lung Surfactants Sales Market Share by Region (2015-2020)
Table 23. Global Lung Surfactants Revenue (Million US$) by Region (2015-2020)
Table 24. Global Lung Surfactants Revenue Market Share by Region (2015-2020)
Table 25. North America Lung Surfactants Sales by Country (2015-2020) (K Units)
Table 26. North America Lung Surfactants Sales Market Share by Country (2015-2020)
Table 27. North America Lung Surfactants Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Lung Surfactants Revenue Market Share by Country (2015-2020)
Table 29. Europe Lung Surfactants Sales by Country (2015-2020) (K Units)
Table 30. Europe Lung Surfactants Sales Market Share by Country (2015-2020)
Table 31. Europe Lung Surfactants Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Lung Surfactants Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Lung Surfactants Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Lung Surfactants Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Lung Surfactants Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Lung Surfactants Revenue Market Share by Region (2015-2020)
Table 37. Latin America Lung Surfactants Sales by Country (2015-2020) (K Units)
Table 38. Latin America Lung Surfactants Sales Market Share by Country (2015-2020)
Table 39. Latin America Lung Surfactants Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Lung Surfactants Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Lung Surfactants Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Lung Surfactants Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Lung Surfactants Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Lung Surfactants Revenue Market Share by Country (2015-2020)
Table 45. Global Lung Surfactants Sales (K Units) by Route of Administration (2015-2020)
Table 46. Global Lung Surfactants Sales Share by Route of Administration (2015-2020)
Table 47. Global Lung Surfactants Revenue (Million US$) by Route of Administration (2015-2020)
Table 48. Global Lung Surfactants Revenue Share by Route of Administration (2015-2020)
Table 49. Global Lung Surfactants Price (US$/Unit) by Route of Administration (2015-2020)
Table 50. Global Lung Surfactants Sales (K Units) by Application (2015-2020)
Table 51. Global Lung Surfactants Sales Market Share by Application (2015-2020)
Table 52. Global Lung Surfactants Sales Growth Rate by Application (2015-2020)
Table 53. Chiesi Farmaceutici Lung Surfactants Corporation Information
Table 54. Chiesi Farmaceutici Description and Business Overview
Table 55. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Chiesi Farmaceutici Main Product
Table 57. Chiesi Farmaceutici Recent Development
Table 58. AbbVie Lung Surfactants Corporation Information
Table 59. AbbVie Corporation Information
Table 60. AbbVie Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. AbbVie Main Product
Table 62. AbbVie Recent Development
Table 63. ONY Biotech Lung Surfactants Corporation Information
Table 64. ONY Biotech Corporation Information
Table 65. ONY Biotech Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. ONY Biotech Main Product
Table 67. ONY Biotech Recent Development
Table 68. Lyomark Pharma Lung Surfactants Corporation Information
Table 69. Lyomark Pharma Corporation Information
Table 70. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Lyomark Pharma Main Product
Table 72. Lyomark Pharma Recent Development
Table 73. Windtree Therapeutics Lung Surfactants Corporation Information
Table 74. Windtree Therapeutics Corporation Information
Table 75. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Windtree Therapeutics Main Product
Table 77. Windtree Therapeutics Recent Development
Table 78. Aviva Systems Biology Corporation Lung Surfactants Corporation Information
Table 79. Aviva Systems Biology Corporation Corporation Information
Table 80. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Aviva Systems Biology Corporation Main Product
Table 82. Aviva Systems Biology Corporation Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Lung Surfactants Distributors List
Table 86. Lung Surfactants Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Lung Surfactants Sales (K Units) Forecast by Route of Administration (2021-2026)
Table 91. Global Lung Surfactants Sales Market Share Forecast by Route of Administration (2021-2026)
Table 92. Global Lung Surfactants Revenue (Million US$) Forecast by Route of Administration (2021-2026)
Table 93. Global Lung Surfactants Revenue (Million US$) Market Share Forecast by Route of Administration (2021-2026)
Table 94. Global Lung Surfactants Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global Lung Surfactants Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Lung Surfactants Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global Lung Surfactants Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Lung Surfactants Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Lung Surfactants Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Lung Surfactants
Figure 2. Global Lung Surfactants Sales Market Share by Route of Administration: 2020 VS 2026
Figure 3. Intratracheal Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Lung Surfactants Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Special Clinic
Figure 8. Recovery Center
Figure 9. Global Lung Surfactants Market Size 2015-2026 (US$ Million)
Figure 10. Global Lung Surfactants Sales Capacity (K Units) (2015-2026)
Figure 11. Global Lung Surfactants Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Lung Surfactants Sales Share by Manufacturers in 2020
Figure 13. Global Lung Surfactants Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Lung Surfactants Revenue in 2019
Figure 15. Lung Surfactants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Lung Surfactants Sales Market Share by Region (2015-2020)
Figure 17. Global Lung Surfactants Sales Market Share by Region in 2019
Figure 18. Global Lung Surfactants Revenue Market Share by Region (2015-2020)
Figure 19. Global Lung Surfactants Revenue Market Share by Region in 2019
Figure 20. North America Lung Surfactants Sales Market Share by Country in 2019
Figure 21. North America Lung Surfactants Revenue Market Share by Country in 2019
Figure 22. U.S. Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Lung Surfactants Sales Market Share by Country in 2019
Figure 27. Europe Lung Surfactants Revenue Market Share by Country in 2019
Figure 28. Germany Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Lung Surfactants Sales Market Share by Region in 2019
Figure 39. Asia Pacific Lung Surfactants Revenue Market Share by Region in 2019
Figure 40. China Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Lung Surfactants Sales Market Share by Country in 2019
Figure 63. Latin America Lung Surfactants Revenue Market Share by Country in 2019
Figure 64. Mexico Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Lung Surfactants Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Lung Surfactants Revenue Market Share by Country in 2019
Figure 72. Turkey Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. UAE Lung Surfactants Sales Growth Rate (2015-2020) (K Units)
Figure 77. UAE Lung Surfactants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Lung Surfactants by Route of Administration (2015-2020)
Figure 79. Sales Market Share of Lung Surfactants by Route of Administration in 2019
Figure 80. Revenue Share of Lung Surfactants by Route of Administration (2015-2020)
Figure 81. Revenue Market Share of Lung Surfactants by Route of Administration in 2019
Figure 82. Global Lung Surfactants Sales Growth by Route of Administration (2015-2020) (K Units)
Figure 83. Global Lung Surfactants Sales Market Share by Application (2015-2020)
Figure 84. Global Lung Surfactants Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Lung Surfactants by Application (2015-2020)
Figure 86. Global Revenue Share of Lung Surfactants by Application in 2020
Figure 87. Chiesi Farmaceutici Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. ONY Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Lyomark Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Windtree Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Aviva Systems Biology Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Price Trend of Key Raw Materials
Figure 94. Manufacturing Cost Structure of Lung Surfactants
Figure 95. Manufacturing Process Analysis of Lung Surfactants
Figure 96. Lung Surfactants Industrial Chain Analysis
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Porter's Five Forces Analysis
Figure 100. North America Lung Surfactants Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. North America Lung Surfactants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Europe Lung Surfactants Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Lung Surfactants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Latin America Lung Surfactants Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Lung Surfactants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Middle East and Africa Lung Surfactants Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Lung Surfactants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Asia Pacific Lung Surfactants Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Lung Surfactants Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed